InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
33%
T+90 mean return
-4.4%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by LUDLUM KEN, Director. Director active across 5 companies, notably Personalis, Inc.. Cumulatively, 9 reports have been published. Activity tracked since 14 May 2021. The latest transaction was filed on 5 December 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations9 total
52,817 shares@ US$1.42100.0% of flowClass A Common StockSEC:0001493152-24-049259:0
39,267 shares@ US$1.91100.0% of flowCommon StockSEC:0001209191-23-037568:0
27,472 shares0Common StockSEC:0001209191-22-037554:0
10,770 shares0Common StockSEC:0001209191-22-030753:0
5,420 shares0Common StockSEC:0001209191-21-042268
5,420 shares0Common StockSEC:0001209191-21-042268:0
2,736 shares0Common StockSEC:0001209191-21-033492
2,736 shares0Common StockSEC:0001209191-21-033492:0
11,000 sharesCommon StockSEC:0000899243-16-012215:0
9 of 9 declarations
About LUDLUM KEN
Ken Ludlum is a Director at Personalis, Inc. and IRIDEX Corp. As a board member, he participates in the governance and strategy of both companies, bringing his expertise in the biotechnology field.
